menu Search
Glipzeal

Glipzeal Special Precautions

sitagliptin

Manufacturer:

ACME Lab

Distributor:

Novocore Pharma
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Full Prescribing Info
Special Precautions
If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated. Dosage adjustment should be recommended in patients with moderate or severe renal insufficiency and patients with ESRD. Assessment of renal function should be recommended before initiating Sitagliptin. When Sitagliptin is used in combination with sulfonylurea or with insulin, medications are known to cause hypoglycemia. If bullous pemphigoid is suspected, sitagliptin should be discontinued. If a hypersensitivity reaction is suspected, the use of Sitagliptin should be discontinued.